Description: Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent protected medical products that improve patient outcomes and save lives in the areas of advanced wound care, infection management and surgical procedures. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) we develop products that we sell under Covalon's name; and (ii) we develop and commercialize medical products for other medical companies under development and license contracts.
Home Page: www.covalon.com
1660 Tech Avenue
Mississauga,
ON
L4W 5S7
Canada
Phone:
905 568 8400
Officers
| Name | Title |
|---|---|
| Mr. Brian E. Pedlar | Pres, CEO & Director |
| Simon Smith | Chief Exec. Officer of Covalon Technologies (Europe) Ltd. |
| Gerry Arambula | Pres of Covalon Technologies AG Ltd. |
| Dr. Valerio DiTizio | Co-Founder, Chief Scientific Officer & VP |
| Mr. Jason F. Gorel | Interim Chief Financial Officer |
| Ms. Elaine Zhang | VP of Operations |
| Mr. Ron Hebert | Sr. VP of Marketing |
| Mr. Greg Leszczynski | VP of HR |
| Mr. Mark Doolittle | Sr. VP of Commercial Sales |
| Mr. Hamed Abbasian | VP of Bus. Devel. |
Exchange: OTCQX
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 33.8 |
| Price-to-Book MRQ: | 2.1239 |
| Price-to-Sales TTM: | 2.2961 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 0 |